The Patent Finder

Claragen, Inc.

Also on record
Records under this name other than patents Claragen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Claragen, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,599,031Optical/electrical interconnects and package for high speed signaling
Formerly held
Term ended
Term ended Sep 12, 2021 · USPTO record
Term endedTerm ended Sep 12, 2021USPTO record
US 7,122,344Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
Formerly held
Term ended
Term ended Sep 22, 2017 · USPTO record
Term endedTerm ended Sep 22, 2017USPTO record
US 6,255,281Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Formerly held
Term ended
Term ended May 28, 2017 · USPTO record
Term endedTerm ended May 28, 2017USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited